Royalty Pharma to Announce Second-Quarter 2021 Financial Results on August 11, 2021
- Wall Street climbs 1% on upbeat results, Fed relief
- Broadcom (AVGO) to Acquire VMware (VMW) for Approximately $61 Billion in Cash and Stock
- NVIDIA (NVDA) Falls on Downbeat Guidance, Evercore ISI Remains a Buyer as Shares Trade Near an 'Estimated Floor of $150'
- Apple (AAPL) Stock Dips on Report It Expects Flat iPhone Production This Year
- Macy's (M) Stock Up 15% on Beat-and-raise, Goldman Sachs Says Results are a 'Bright Spot Among Retailers'
|REPROS THERAPEUTICS (NASDAQ: RPRX)||Delayed: 40.57 +0.36 (0.90%)|
|Previous Close||$40.21||52 Week High||$3.48|
|Open||$40.52||52 Week Low||$0.80|